Dr. Charles Conway at Washington University is study studying the use of a genetic tool to improve outcomes for individuals who have never taken an antidepressant. The tool classifies the likelihood to respond to antidepressants. Initial criteria includes:

  • Age 18 to 65 
  • Currently experience depression
  • Have never taken medication for depression
  • No history of schizophrenia or bipolar disorder
  • No history of gastric bypass surgery

For more information, call 314-273-1921.